Literature DB >> 31432718

Risk factors of gestational diabetes mellitus during assisted reproductive technology procedures.

Hu Shiqiao1, Xu Bei1, Zhang Yini1, Jin Lei1.   

Abstract

To investigate risk factors of gestational diabetes mellitus (GDM) during assisted reproductive technology (ART) procedures. A total of 1022 patients were included in this retrospective cohort study from January 1, 2014 to August 31, 2017. While patients were divided into two groups: the non- GDM group and the GDM group. There was no significant difference in basal FSH, AFC, infertility years, gestational age, number of fetus, method of fertilization, and reason of infertility between the two groups. However, age, BMI, and fresh cycle were verified to be association with GDM by using logistic regression model. During the process of controlled ovarian hyperstimulation (COH), estradiol (E2) was significantly lower in the GDM group. The incidence of GDM was highest when E2 level less than 200 pg/mL of per oocyte. Our study showed maternal fundamental factors had greater impacts on subsequent GDM.

Entities:  

Keywords:  Assisted reproductive technology; BMI; age; estradiol; gestational diabetes mellitus

Year:  2019        PMID: 31432718     DOI: 10.1080/09513590.2019.1648418

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  2 in total

1.  Dose-response association between maternal pre-pregnancy bodyweight and gestational diabetes mellitus following ART treatment: a population-based cohort study.

Authors:  Yiquan Xiong; Jing Wang; Yana Qi; Chunrong Liu; Mingxi Li; Guanhua Yao; Wei Sun; Yongyao Qian; Lishan Ye; Hui Liu; Qiushi Xu; Kang Zou; Jing Tan; Xin Sun
Journal:  Reprod Biol Endocrinol       Date:  2022-06-22       Impact factor: 4.982

2.  Blastocyst Transfer: A Risk Factor for Gestational Diabetes Mellitus in Women Undergoing In Vitro Fertilization.

Authors:  Huijun Chen; Jian Li; Sufen Cai; Sha Tang; Suimin Zeng; Chang Chu; Carl-Friedrich Hocher; Benjamin Rösing; Bernhard K Krämer; Liang Hu; Ge Lin; Fei Gong; Berthold Hocher
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.